Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway
Thursday, July 24, 2008 - 12:28
in Health & Medicine
Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that the efficacy of imiquimod, a clinically important immune response modifier with potent antiviral and antitumor activity, is dependent on the Opioid Growth Factor (OGF)-OGF receptor (OGFr) axis for its action.
Read the whole article on Physorg
More from Physorg
Related
- Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathwayThu, 24 Jul 2008, 13:29:44 EDT
- Regulation of cell proliferation by the OGF-OGFr axis is dependent on nuclear localization signalsThu, 23 Apr 2009, 10:45:14 EDT
- How cells die determines whether immune system mounts responseThu, 17 Jul 2008, 12:35:45 EDT
- Elderly immune system needs a boostThu, 8 Oct 2009, 11:00:59 EDT
- Brain structure assists in immune response, according to Penn vet studyWed, 28 Jan 2009, 13:23:36 EST